CCL5/RANTES gene polymorphisms in Slavonic patients with myocardial infarction
Language English Country United States Media print-electronic
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
21547257
PubMed Central
PMC3086320
DOI
10.1155/2011/525691
Knihovny.cz E-resources
- MeSH
- White People genetics MeSH
- Chemokine CCL5 genetics immunology MeSH
- Adult MeSH
- Genetic Predisposition to Disease MeSH
- Genotype MeSH
- Myocardial Infarction genetics immunology MeSH
- Polymorphism, Single Nucleotide * MeSH
- Middle Aged MeSH
- Humans MeSH
- Coronary Artery Disease genetics MeSH
- Promoter Regions, Genetic MeSH
- Aged MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
- Russia MeSH
- Names of Substances
- Chemokine CCL5 MeSH
Coronary artery inflammation is a critical process in the pathogenesis of myocardial infarction (MI). The chemokine CCL5/RANTES (regulated upon activation, normal T cells expressed and secreted) is expressed in advanced atherosclerotic lesions. Functional polymorphisms of the RANTES gene can, therefore, be involved in the pathogenesis of coronary artery disease. We examined the association of polymorphisms in the RANTES gene with myocardial infarction in Slavonic populations of Czech and Russian origin. A total of 467 post-MI patients and 337 control subjects were genotyped for RANTES promoter G-403A (rs2107538) and intron 1.1 T/C (rs2280789) variants by PCR-SSP. Both RANTES genotypes and allele frequencies did not differ between case and control groups. Haplotype-based analysis also failed to reveal an association between MI and investigated markers. Strong linkage disequilibrium was detected between particular RANTES alleles. The data do not support an association between RANTES G-403A polymorphism and MI, as reported previously.
See more in PubMed
Hansson GK. Immune and inflammatory mechanisms in the development of atherosclerosis. British Heart Journal. 1993;69(supplement 1):S38–S41. PubMed PMC
Libby P, Theroux P. Pathophysiology of coronary artery disease. Circulation. 2005;111(25):3481–3488. PubMed
Pattison JM, Nelson PJ, Huie P, Sibley RK, Krensky AM. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. Journal of Heart and Lung Transplantation. 1996;15(12):1194–1199. PubMed
Mause SF, Von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arteriosclerosis, Thrombosis, and Vascular Biology. 2005;25(7):1512–1518. PubMed
Schober A, Manka D, Von Hundelshausen P, et al. Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation. 2002;106(12):1523–1529. PubMed
Hajeer AH, Al Sharif F, Ollier WER. A polymorphism at position -403 in the human RANTES promoter. European Journal of Immunogenetics. 1999;26(5):375–376. PubMed
An P, Nelson GW, Wang L, et al. Modulating influence on HIV/AIDS by interacting RANTES gene variants. Proceedings of the National Academy of Sciences of the United States of America. 2002;99(15):10002–10007. PubMed PMC
Simeoni E, Winkelmann BR, Hoffmann MM, et al. Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis. European Heart Journal. 2004;25(16):1438–1446. PubMed
Szalai C, Duba J, Prohászka Z, et al. Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis. 2001;158(1):233–239. PubMed
Böger CA, Fischereder M, Deinzer M, et al. RANTES gene polymorphisms predict all-cause and cardiac mortality in type 2 diabetes mellitus hemodialysis patients. Atherosclerosis. 2005;183(1):121–129. PubMed
McDermott DH, Beecroft MJ, Kleeberger CA, et al. Chemokine RANTES promoter polymorphism affects risk of both HIV infection and disease progression in the Multicenter AIDS Cohort Study. AIDS. 2000;14(17):2671–2678. PubMed
Liu H, Chao D, Nakayama EE, et al. Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(8):4581–4585. PubMed PMC
Kusano F, Tanaka Y, Marumo F, Sato C. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C. Laboratory Investigation. 2000;80(3):415–422. PubMed
Duan ZP, Zhao XY, Huang DZ, et al. RANTES gene single nucleotide polymorphisms and expression in patients with chronic hepatitis B virus infection. Chinese Medical Journal. 2005;118(11):909–914. PubMed
Alpert JS, Antman E, Apple F, et al. Myocardial infarction redefined—a consensus document of the Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarction. European Heart Journal. 2000;21(18):1502–1513. PubMed
Bunce M, O’Neill CM, Barnardo MCNM, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP) Tissue Antigens. 1995;46(5):355–367. PubMed
Cooke GS, Tosh K, Ramaley PA, et al. A polymorphism that reduces RANTES expression is associated with protection from death in HIV-seropositive Ugandans with advanced disease. Journal of Infectious Diseases. 2006;194(5):666–669. PubMed
Hizawa N, Yamaguchi E, Konno S, Tanino Y, Jinushi E, Nishimura M. A functional polymorphism in the RANTES gene promoter is associated with the development of late-onset asthma. American Journal of Respiratory and Critical Care Medicine. 2002;166(5):686–690. PubMed
Nickel RG, Casolaro V, Wahn U, et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. Journal of Immunology. 2000;164(3):1612–1616. PubMed
Fryer AA, Spiteri MA, Bianco A, et al. The -403 G→a promoter polymorphism in the RANTES gene is associated with atopy and asthma. Genes and Immunity. 2000;1(8):509–514. PubMed
Novel insights into miRNA in lung and heart inflammatory diseases